tiprankstipranks
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
US Market
KTTA
Pasithea Therapeutics Corp
RESEARCH TOOLSreports

Pasithea Therapeutics Corp (KTTA) Income Statement

148 Followers

Pasithea Therapeutics Corp Income Statement

Last quarter (Q4 2025), Pasithea Therapeutics Corp's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Pasithea Therapeutics Corp's net income was $-10.11M. See Pasithea Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 15.06K
Gross Profit
$ -662.59K$ 0.00$ 0.00$ -5.09K$ -2.21K
Operating Expenses
$ 20.19M$ 14.25M$ 15.98M$ 12.58M$ 4.51M
Depreciation and Amortization
$ 662.59K$ 649.03K$ 648.45K$ 5.09K$ 1.38K
EBITDA
$ -20.19M$ -13.60M$ -15.33M$ -11.72M$ -4.51M
Operating Income
$ -20.86M$ -14.25M$ -15.98M$ -12.59M$ -4.51M
Other Income/Expenses
$ 429.61K$ 345.38K$ 471.61K$ 861.09K$ 2.33M
Pretax Income
$ -20.43M$ -13.90M$ -15.51M$ -11.73M$ -2.17M
Net Income
$ -20.43M$ -13.90M$ -15.96M$ -13.94M$ -2.17M
Per Share Metrics
Basic EPS
$ -2.91$ -12.69$ -12.65$ -10.34$ -1.89
Diluted EPS
$ -2.91$ -12.69$ -13.01$ -10.34$ -1.89
Weighted Average Shares Outstanding
 7.03M 1.10M 1.26M 1.26M 1.15M
Weighted Average Shares Outstanding (Diluted)
 7.03M 1.10M 1.23M 1.26M 1.15M
Currency in USD

Pasithea Therapeutics Corp Earnings and Revenue History